loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

The lab’s study on problematic opioid use is gathering media attention!

The manuscript entitled ‘Genome-wide association study of problematic opioid prescription use in 132,113 23andMe research participants of European ancestry’ was recently published in Molecular Psychiatry and is already gathering media attention (read about it here and here)!


The manuscript was also featured in a 23andMe blog post about opioid use disorder (read it here)!

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING

loading-indicator

LOADING